Answer
During mavacamten treatment, new or worsening breathlessness, chest pain, fatigue, palpitations, leg swelling or elevated NT-proBNP may indicate systolic dysfunction and should prompt evaluation of cardiac function.
Sources for this answer
- Mavacamten BMS 2.5 mg, 5 mg, 10 mg, 15 mg hard capsulesBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 6Document updated
Sources checked